分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Novel DPY19L2 variants in globozoospermic patients and the overcoming this male infertility

Yong-Liang Shang, Fu-Xi Zhu, Jie Yan, Liang Chen, Wen-Hao Tang, Sai Xiao, Wei-Ke Mo, Zhi-Guo Zhang, Xiao-Jin He, Jie Qiao, Yun-Xia Cao, Wei Li

Journal:ASIAN JOURNAL OF ANDROLOGY

IF:3.26

DOI:10.4103/aja.aja_79_18

PMID:

Published:2018-10-16

research field:分子生物学生殖医学遗传学

Abstract

Globozoospermia has been reported to be a rare but severe causation of male infertility, which results from the failure of acrosome biogenesis and sperm head shaping. Variants of dpy-19-like 2 (DPY19L2) are highly related to globozoospermia, but related investigations have been mainly performed in patients from Western countries. Here, we performed a screening of DPY19L2 variants in a cohort of Chinese globozoospermic patients and found that five of nine patients carried DPY19L2 deletions and the other four patients contained novel DPY19L2 point mutations, as revealed by whole-exome sequencing. Patient 3 (P3) contained a heterozygous variant (c.2126+5G>A), P6 contained a homozygous nonsense mutation (c.1720C>T, p.Arg574*), P8 contained compound heterozygous variants (c.1182-1184delATC, p.Leu394_Ser395delinsPhe; c.368A>T, p.His123Arg), and P9 contained a heterozygous variant (c.1182-1184delATCTT, frameshift). We also reported intracytoplasmic sperm injection (ICSI) outcomes in the related patients, finding that ICSI followed by assisted oocyte activation (AOA) with calcium ionophore achieved high rates of live births. In summary, the infertility of these patients results from DPY19L2 dysfunction and can be treated by ICSI together with AOA.

本文使用的Yeasen产品

相关产品
购物车
客服
转染试用